课题基金 / 基金详情

Development and implementation of decision-aid to improve patients' knowledge and decision-making quality for catheter-based atrial fibrillation ablation: A randomized clinical trial (IMPROVE-AF).

Development and implementation of decision-aid to improve patients' knowledge and decision-making quality for catheter-based atrial fibrillation ablation: A randomized clinical trial (IMPROVE-AF).
开发和实施决策辅助，以提高患者对基于导管的房颤消融的知识和决策质量：一项随机临床试验（IMPROVE-AF）。
批准号：
317633
负责人：
Ha Andrew C
金额：
$10.2万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Randomized Controlled Trials
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-10-01 至 2016-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=317633&lang=en
关键词：
Atrial Fibrillation Catheter Ablation For Af Knowledge Translation Patient Decision Aids Quality Of Life Randomized Clinical Trials Shared Decision Making Stroke Prevention

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A major treatment goal for patients with atrial fibrillation (AF) is to improve their symptoms and quality of life. Catheter ablation is a useful therapy for selected patients with symptomatic AF. However, this therapy has risks, is costly, and is not suc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金